Deep Space

Deep Space Biology is a private U.S. biotechnology and health-technology company focused on applying explainable AI, multi-omics integration, and space-biology data to accelerate discovery in human health. Its core product is YOTTA, a bio-discovery AI platform designed to identify disease targets, biomarkers, pathways, and mechanism-of-action insights from terrestrial and microgravity-derived datasets. The company positions itself as a platform business serving biotech, pharma, healthcare, and academic research partners rather than as a developer of a disclosed therapeutic asset pipeline. Deep Space Biology also works at the intersection of space biotech and precision medicine, aiming to translate biological insights from space research into diagnostics, drug discovery, and translational research applications on Earth. The company has highlighted collaborations involving NASA GeneLab-related work, KAUST, and participation in an MD Anderson-led ISS research project.